We are live on ! Find out more
WST icon

West Pharmaceutical
WST

379 hedge funds and large institutions have $7.5B invested in West Pharmaceutical in 2019 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 142 increasing their positions, 96 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

63% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 40

48% more repeat investments, than reductions

Existing positions increased: 142 | Existing positions reduced: 96

11% more capital invested

Capital invested by funds: $6.76B → $7.5B (+$740M)

7% more funds holding

Funds holding: 355 → 379 (+24)

1.68% less ownership

Funds ownership: 94.03% → 92.35% (-1.7%)

89% less call options, than puts

Call options by funds: $3.06M | Put options by funds: $26.7M

Holders
379
Holders Change
+24
Holders Change %
+6.76%
% of All Funds
8.2%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.11%
New
65
Increased
142
Reduced
96
Closed
40
Calls
$3.06M
Puts
$26.7M
Net Calls
-$23.6M
Net Calls Change
-$17.9M

Top Buyers

1
Capital Research Global Investors
Capital Research Global Investors
California
+$55.6M
2
Renaissance Technologies
Renaissance Technologies
New York
+$29.2M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$23.1M
4
Millennium Management
Millennium Management
New York
+$20.8M
5
BlackRock
BlackRock
New York
+$17.9M

Top Sellers

1
1832 Asset Management
1832 Asset Management
Ontario, Canada
-$86.1M
2
William Blair Investment Management
William Blair Investment Management
Illinois
-$73.5M
3
TG
TCW Group
California
-$56.9M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$49M
5
Franklin Resources
Franklin Resources
California
-$29M
Name Holding Trade Value Shares
Change 		Change in
Stake
WAP
376
Wealthcare Advisory Partners
Pennsylvania
$1K – – –
PFGIA
377
Patriot Financial Group Insurance Agency
Massachusetts
$1K +$624 +6 New
GT
378
Glenmede Trust
Pennsylvania
$693 -$26K -250 -4%
1832 Asset Management
379
1832 Asset Management
Ontario, Canada
– -$86.1M -878,420 Closed
William Blair Investment Management
380
William Blair Investment Management
Illinois
– -$73.5M -749,634 Closed
KCM
381
Kornitzer Capital Management
Kansas
– -$21.9M -223,625 Closed
Adage Capital Partners
382
Adage Capital Partners
Massachusetts
– -$12.7M -130,000 Closed
Bank of Nova Scotia
383
Bank of Nova Scotia
Ontario, Canada
– -$4.21M -43,000 Closed
CM
384
Castleark Management
Illinois
– -$2.46M -25,105 Closed
DTL
385
Dynamic Technology Lab
Singapore
– -$1.71M -17,417 Closed
AI
386
Atom Investors
Texas
– -$1.63M -16,629 Closed
SSA
387
Schonfeld Strategic Advisors
New York
– -$1.02M -10,444 Closed
Balyasny Asset Management
388
Balyasny Asset Management
Illinois
– -$814K -8,305 Closed
MWNA
389
Marshall Wace North America
New York
– -$743K -7,584 Closed
OAM
390
Oxford Asset Management
United Kingdom
– -$636K -6,484 Closed
BAS
391
Brown Advisory Securities
Maryland
– -$622K -6,440 Closed
WCM
392
Weld Capital Management
New York
– -$448K -4,567 Closed
FRM
393
Fox Run Management
Connecticut
– -$430K -4,385 Closed
GCA
394
Gideon Capital Advisors
New York
– -$403K -4,109 Closed
CBA
395
Coastal Bridge Advisors
Connecticut
– -$284K -2,900 Closed
PM
396
Parametrica Management
Hong Kong
– -$267K -2,728 Closed
V
397
Veritable
Delaware
– -$256K -2,612 Closed
Two Sigma Advisers
398
Two Sigma Advisers
New York
– -$245K -2,500 Closed
Mackenzie Financial
399
Mackenzie Financial
Ontario, Canada
– -$241K -2,455 Closed
VF
400
Virtu Financial
New York
– -$239K -2,436 Closed
13 14 15
16
17

WST Hedge Fund Activity: Q1 2019 in Review

379 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q1 2019, worth a combined $7.5B — up 11% from $6.76B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new WST positions and 40 closed out — a net gain of 25 holders — while 142 added to existing stakes and 96 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $55.6M. The largest seller was 1832 Asset Management, exiting entirely with an estimated $86.1M sold.

  • 379 institutional investors held West Pharmaceutical (WST) as of Q1 2019, up from 355 in Q4 2018.
  • Funds reported $7.5B of West Pharmaceutical stock for Q1 2019, up 11% quarter-over-quarter.
  • 65 funds opened new West Pharmaceutical positions in Q1 2019 and 40 closed out, a net change of +25 holders.
  • The largest West Pharmaceutical buyer in Q1 2019 was Capital Research Global Investors, an estimated $55.6M added.
  • The largest West Pharmaceutical seller in Q1 2019 was 1832 Asset Management, an estimated $86.1M sold.

Based on aggregated 13F filings for Q1 2019.